Advertisement
Research ArticleCardiovascular

Proximal Tubule β2-Adrenergic Receptor Mediates Formoterol-Induced Recovery of Mitochondrial and Renal Function after Ischemia-Reperfusion Injury

Robert B. Cameron, Whitney S. Gibbs, Siennah R. Miller, Tess V. Dupre, Judit Megyesi, Craig C. Beeson and Rick G. Schnellmann
Journal of Pharmacology and Experimental Therapeutics April 2019, 369 (1) 173-180; DOI: https://doi.org/10.1124/jpet.118.252833

Abstract

Acute kidney injury (AKI) is the rapid loss of renal function after an insult, and renal proximal tubule cells (RPTCs) are central to the pathogenesis of AKI. The β2-adrenergic receptor (β2AR) agonist formoterol accelerates the recovery of renal function in mice after ischemia-reperfusion injury (IRI) with associated rescue of mitochondrial proteins; however, the cell type responsible for this recovery remains unknown. The role of RPTCs in formoterol-induced recovery of renal function was assessed in a proximal tubule–specific knockout of the β2AR (γGT-Cre:ADRB2Flox/Flox). These mice and wild-type controls (ADRB2Flox/Flox) were subjected to renal IRI, followed by once-daily dosing of formoterol beginning 24 hours post-IRI and euthanized at 144 hours. Compared with ADRB2Flox/Flox mice, γGT-Cre:ADRB2Flox/Flox mice had decreased renal cortical mRNA expression of the β2AR. After IRI, formoterol treatment restored renal function in ADRB2Flox/Flox but not γGT-Cre:ADRB2Flox/Flox mice as measured by serum creatinine, histopathology, and expression of kidney injury marker-1 (KIM-1). Formoterol-treated ADRB2Flox/Flox mice exhibited recovery of mitochondrial proteins and DNA copy number, whereas γGT-Cre:ADRB2Flox/Flox mice treated with formoterol did not. Analysis of mitochondrial morphology by transmission electron microscopy demonstrated that formoterol increased mitochondrial number and density in ADRB2Flox/Flox mice but not in γGT-Cre:ADRB2Flox/Flox mice. These data demonstrate that proximal tubule β2AR regulates renal mitochondrial homeostasis. Formoterol accelerates the recovery of renal function after AKI by activating proximal tubule β2AR to induce mitochondrial biogenesis and demonstrates the overall requirement of RPTCs in renal recovery.

Introduction

Acute kidney injury (AKI) is a rapid loss of renal function that occurs in more than 20% of hospitalized patients and has a mortality rate of 25% (Susantitaphong et al., 2013; Hoste et al., 2015). AKI has numerous causes, including hypotension, nephrotoxic drug administration, and renal ischemia-reperfusion injury (IRI) (Moore et al., 2018). Unfortunately, treatment of AKI remains limited to supportive care and renal replacement therapy.

The difficulty in treating AKI is the numerous cell types involved, including immune cells (Jang and Rabb, 2015), endothelial cells (Molitoris, 2014), and the renal epithelium (Liu et al., 2018). Renal proximal tubule cells (RPTCs) are a highly oxidative and regenerative cell type that plays a central role in the pathogenesis of AKI (Sekine et al., 2012; Ralto and Parikh, 2016). RPTCs exhibit mitochondrial fragmentation and dysfunction with persistent suppression of mitochondrial biogenesis (MB) after AKI (Brooks et al., 2009; Tran et al., 2011; Funk and Schnellmann, 2012). Transgenic mouse models have shown that decreased MB worsens AKI, whereas increased MB accelerates recovery (Tran et al., 2016).

Drugs that increase MB accelerate recovery from AKI with concomitant rescue of mitochondrial protein expression and function (Wills et al., 2012). One such drug is the Food and Drug Administration–approved β2-adrenergic receptor (β2AR) agonist formoterol (Wills et al., 2012). We reported that formoterol treatment restored renal function with concomitant increases in mitochondrial protein expression and function after AKI in mice (Jesinkey et al., 2014). We also elucidated the mechanism of formoterol-induced MB in RPTCs (Cameron et al., 2017). Formoterol binding to the β2AR results in the release of Gβγ heterodimer, the activation of protein kinase B, the phosphorylation of endothelial nitric oxide synthase, and increased soluble guanylyl cyclase activity and cGMP. This pathway increased peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α), the master regulator of MB (Puigserver et al., 1998), with concomitant induction of MB.

Because the β2AR is ubiquitously expressed (e.g., T cells, macrophages, neutrophils, endothelial cells, and RPTCs), it is not clear which cell(s) are responsible for formoterol- induced MB and recovery of renal function after IR-induced AKI. The goal of this study was to determine the specific role of RPTC β2AR in AKI and formoterol-induced recovery of mitochondrial and renal function using a mouse with proximal tubule–specific deletion of the β2AR (Iwano et al., 2002).

Materials and Methods

Animal Use.

ADRB2Flox/Flox mice (Hinoi et al., 2008) were a generous gift from Drs. Zhi Zhong and Gerard Karsenty and were mated with γGT-Cre mice (Iwano et al., 2002), a generous gift from Dr. Leslie Gewin, to generate γGT-Cre:ADRB2Flox/Flox mice. These mice were generated on a C57Bl/6 background, and male 8- to 10-week-old littermates were subjected to bilateral renal ischemia-reperfusion injury as previously described (Funk and Schnellmann, 2012). Dosing was initiated 24 hours after reperfusion, and mice were given a daily injection of 0.3 mg/kg formoterol fumarate dihydrate (F9552; Sigma-Aldrich, St. Louis, MO) or vehicle [0.3% dimethylsulfoxide (DMSO) in normal saline] via intraperitoneal injection. Blood was collected by retro-orbital bleeding puncture, and serum creatinine (SCr) level was determined using the Creatinine Enzymatic Reagent Assay kit (Diazyme Laboratories, Inc., La Jolla, CA) according to the manufacturer’s protocol. All experiments were carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All procedures were approved by the University of Arizona Institutional Animal Care and Use Committee, and appropriate efforts were made to reduce animal suffering.

Nucleic Acid Isolation and Quantitative Polymerase Chain Reaction.

RNA was extracted from frozen renal cortex in TRIzol isolated using a phenol-based centrifugation method (Life Technologies, Grand Island, NY). cDNA was reversed- transcribed using the iScript Advanced cDNA Synthesis Kit (BioRad, Hercules, CA) and added to a real-time SYBR Green quantitative polymerase chain reaction master mix (BioRad). Changes in gene expression were calculated based on the Δ-Δ threshold cycle method. Primers are reported in Supplemental Materials.

Mouse-tail tips were lysed using Direct PCR (polymerase chain reaction) lysis reagent (ViaGen, Inc., Cedar Park, TX). Genomic DNA was amplified using Promega 2X PCR Master Mix (Promega, Madison, WI) in accordance with manufacturer’s protocols. Amplified DNA was separated on a 2.5% agarose gel and visualized by ethidium bromide fluorescence. ADRB2Flox alleles were distinguished from ADRB2+ alleles based on fragment size as previously described (Hinoi et al., 2008).

To measure mtDNA copy number, DNA was extracted from frozen renal cortex using the DNeasy Blood and Tissue kit (QIAGEN, Valencia, CA). PCR products were amplified from 5 ng of cellular DNA using a real-time SYBR Green quantitative PCR (BioRad). For estimation of mtDNA, the NADH dehydrogenase subunit 6 (ND6) gene was used and normalized to β-actin.

Protein Isolation and Immunoblotting.

Frozen renal cortex was suspended in protein lysis buffer (1% Triton X-100, 150 mM NaCl, and 10 mM Tris-HCl, pH 7.4; 1 mM EDTA; 1 mM EGTA; 2 mM sodium orthovanadate; 0.2 mM phenylmethylsulfonyl fluoride; 1 mM HEPES, pH 7.6) containing protease inhibitors and phosphatase inhibitors (Sigma-Aldrich). Affter sonication, protein was quantified using a bicinchoninic acid assay, subjected to SDS-PAGE, transferred onto nitrocellulose membranes, and incubated with primary and secondary antibodies. Membranes were detected using chemiluminescence and processed using ImageJ (National Institutes of Health, Bethesda, MD) software. Antibodies are reported in Supplemental Materials.

Electron Microscopy.

Renal cortex was fixed and sectioned for transmission electron microscopy. Images were viewed by FEI Tecnai Spirit microscope operated at 100 kV and captured using an AMT 4 Mpixel camera. Mitochondrial count and morphology were analyzed using the Trainable Weka Segmentation plugin in ImageJ.

Histopathology.

Kidney sections (approximately 5 to 6 μm) from animals 144 hours after IR or sham surgery were stained with H&E and periodic acid-Schiff, and the degree of morphologic changes was determined by light microscopy in a blinded fashion. Loss of brush border and necrosis were chosen as indicators of morphologic damage to the kidney. These measures were evaluated on a scale from 0 to 4, which ranged from not present (0), mild (1), moderate (2), severe (3), and very severe (4).

Statistical Analysis.

Data are expressed as means ± S.E.M. (n ≥ 3) for all experiments. Each n represents a different animal. Multiple comparisons of normally distributed data were analyzed by two-way analysis of variance. Single comparisons were analyzed using a t test where appropriate. The criterion for statistical differences was P < 0.05 for all comparisons.

Results

RPTC-specific deletion of the β2AR in mice was achieved by breeding γGT-Cre mice with ADRB2Flox/Flox (wild-type, WT) mice to create a γGT-Cre:ADRB2Flox/Flox mouse (kmockout, KO) (Fig. 1A). The presence of ADRB2Flox alleles was determined by DNA electrophoresis. Tail tips were digested, and genomic DNA was amplified. As previously described (Hinoi et al., 2008), the ADRB2Flox allele has a longer sequence than the ADRB2+ allele, allowing for discrimination of ADRB2+/+ (one low band), ADRB2Flox/+ (one high band and one low band), and ADRB2Flox/Flox (one high band) mice. Deletion of ADRB2 and appropriate expression of the Cre transgene was assessed by qPCR using renal cortical DNA. Expression of ADRB2 was assessed by RT-qPCR using renal cortical mRNA. Consistent with the loss of β2AR in RPTCs, KO mice had an 80% reduction in renal cortical ADRB2 DNA and mRNA expression and increased γGT-Cre DNA expression relative to WT mice (Fig. 1, B–D).

Fig. 1.
Fig. 1.

γGT-Cre:ADRB2Flox/Flox mice have proximal tubule specific deletion of the β2 adrenergic receptor. (A) DNA electrophoresis of: an ADRB2+/+ mouse homozygous for ADRB2+ (lane 1) and not expressing γGT-Cre (lane 2); a mouse γGT-Cre:ADRB2+/+ homozygous for ADRB2+ (lane 3) and expressing γGT-Cre (lane 4); and a γGT-Cre:ADRB2Flox/Flox mouse homozygous for ADRB2Flox (lane 5) and expressing γGT-Cre (lane 6). (B) RT-PCR of ADRB2 mRNA in ADRB2Flox/Flox and γGT-Cre:ADRB2Flox/Flox mice. (C and D) PCR of ADRB2 (C) and γGT-Cre (D) DNA. All samples are from the renal cortex. Mean ± S.E.M. n = 4 to 5, *P < 0.05, Student’s t test.

The role of RPTC β2AR on recovery from AKI was determined in KO and WT mice subjected to renal IRI, followed by treatment with vehicle or formoterol (0.3 mg/kg, i.p) after 24 hours and then daily for 144 hours. WT and KO mice had similar increases in SCr at 24 hours, indicating no difference in initial injury (Fig. 2A). As previously described, (Jesinkey et al., 2014) WT mice treated with formoterol exhibited recovery from AKI at 144 hours as measured by decreases in SCr and renal cortical kidney injury marker-1 (KIM-1) protein (Fig. 2, B and F). In contrast, KO mice treated with formoterol did not exhibit decreases in SCr and renal cortical KIM-1 at 144 hours. These findings were confirmed by histopathology in that formoterol-treated WT mice had less necrosis than did vehicle-treated animals, whereas formoterol failed to decrease necrosis in KO mice at 144 hours (Fig. 2, C and D). Together, these findings provide evidence that, after AKI, formoterol exerts its effects on renal recovery by activating the RPTC β2AR.

Fig. 2.
Fig. 2.

Proximal tubule deletion of the β2AR blocks the effects of formoterol on renal function after AKI. ADRB2Flox/Flox and γGT-Cre:ADRB2Flox/Flox mice were subjected to sham or renal IRI surgery. Mice were treated with 0.3% DMSO (vehicle) or 0.3 mg/kg formoterol (formoterol) once daily beginning at 24 hours and were euthanized at 144 hours. (A and B) Serum creatinine at 24 (A) and 144 hours (B) after IR. (C) PAS-stained kidney sections. (D and E) Semiquantitative scoring of tubular necrosis (D) and loss of brush border (E). (F) Representative blot of renal cortical KIM-1 at 144 h after IRI. FFS-ADRB2Flox/Flox sham, FFV-ADRB2Flox/Flox IR+0.3% DMSO, FFF-ADRB2Flox/Flox IR+0.3 mg/kg formoterol, CFS-γGT-Cre:ADRB2Flox/Flox Sham, CFV- γGT-Cre:ADRB2Flox/Flox IR+0.3% DMSO, CFF- γGT-Cre:ADRB2Flox/Flox IR + formoterol. Mean ± S.E.M. n = 4–9. Different letters denote P < 0.05, two-way analysis of variance (ANOVA) with Fisher’s least significant difference (LSD) test.

RPTCs have high mitochondrial content to maintain proper solute transport across the tubular lumen (Nakamura et al., 2014; Chevalier, 2016; Ralto and Parikh, 2016). After AKI, MB is persistently suppressed, and recovery of mitochondrial content is associated with recovery of renal function and improved outcomes (Tran et al., 2011). The effects of RPTC β2AR on mitochondrial content were assessed by measuring mtDNA and mitochondrial proteins using quantitative PCR and immunoblot analysis, respectively. Formoterol restored mtDNA copy number in WT but not in KO mice after IRI (Fig. 3A). Similarly, KO mice subjected to IRI and treated with formoterol demonstrated no recovery of nuclear-encoded NADH:ubiquinone oxidoreductase core subunit S1 (NDUFS1) and the mitochondrial-encoded cytochrome c oxidase subunit 1(COX1), electron transport chain proteins, and markers of MB (Fig. 3B). Thus, activation of RPTC β2AR by formoterol rescues markers of MB after AKI. Interestingly, KO shams had elevated expression of NDUFS1, which suggests that the β2AR may regulate mitochondrial homeostasis in healthy RPTCs.

Fig. 3.
Fig. 3.

Proximal tubule cell β2AR mediates formoterol-induced rescue of mitochondrial homeostasis after IRI-AKI. (A) Mitochondrial DNA copy number. (B) Representative blots and quantification of nuclear-encoded (NDUFS1) and mitochondrial-encoded (COX1) proteins in renal cortex 144 hours after IRI. (C) Representative blots and quantification of mitochondrial dynamic proteins Mfn2 and Drp1 in renal cortex 144 hours after IRI. FFS-ADRB2Flox/Flox sham, FFV-ADRB2Flox/Flox IR + 0.3% DMSO, FFF-ADRB2Flox/Flox IR + 0.3 mg/kg formoterol, CFS-γGT-Cre:ADRB2Flox/Flox sham, CFV- γGT-Cre:ADRB2Flox/Flox IR + 0.3% DMSO, CFF- γGT-Cre:ADRB2Flox/Flox IR + 0.3 mg/kg formoterol. Mean ± S.E.M. n = 4–9. Different letters denote P < 0.05, Two-way analysis of variance (ANOVA) with Fisher’s least significant difference (LSD) test.

In addition to the restoration of electron transport chain proteins, formoterol restored mitochondrial fission and fusion proteins dynamin-related protein 1 (Drp1) and mitofusin (Mfn2), respectively, in WT but not in KO mice (Fig. 3C). Because Drp1 and Mfn2 affect mitochondrial dynamics, we assessed mitochondrial morphology using transmission electron microscopy. Electron micrographs were obtained, and mitochondrial morphology and number were quantified using ImageJ and the Trainable Weka Segmentation plugin. We observed no changes in mitochondrial form factor or individual mitochondrial area, suggesting that formoterol did not affect mitochondrial fission and fusion at 144 hours (Fig. 4, A–C); however, in WT mice, renal cortical mitochondrial number and total mitochondria area decreased after IRI, and formoterol restored these parameters, indicating that formoterol induced MB (Fig. 4, D and E). Sham-operated KO mice had fewer mitochondria, providing evidence that RPTC β2AR regulates mitochondrial homeostasis under physiologic conditions. Together, these data indicate that formoterol activates RPTC β2AR to induce MB and accelerate recovery of renal function after AKI.

Fig. 4.
Fig. 4.

The role of proximal tubule cell β2 adrenergic receptor on mitochondrial content and morphology in renal cortex. (A) Representative electron micrographs of ADRB2Flox/Flox and γGT-Cre:ADRB2Flox/Flox subjected to sham or IRI surgery, followed by treatment with 0.3% DMSO or 0.3 mg/kg formoterol daily for 144 hours. (B) Quantification of individual mitochondrial area. (C) Quantification of average mitochondrial form factor. (D) Quantification of mitochondria per field. (E) Quantification of total mitochondrial area per field. All images were acquired at ×8200 magnification with at least five fields per animal. n = 3–8. Mean ± S.E.M. Different letters indicate P < 0.05, Two-way analysis of variance (ANOVA) with Fisher’s least significant difference (LSD) test.

Discussion

We demonstrated that RPTC β2AR is responsible for the effects of formoterol on renal function after AKI. Previous studies in septic AKI demonstrated that overexpression or activation of the β2AR by terbutaline prevents apoptosis, decreases injury, and promotes recovery of renal function (Nakamura et al., 2003, 2004, 2005, 2010); however, in these studies, excessive activation of the β2AR decreased serum creatinine (Nakamura et al., 2007). We have shown that selective and limited activation of the β2AR by formoterol accelerates recovery from IR-induced AKI (Jesinkey et al., 2014), and in these studies, we have shown that formoterol does so by activating RPTC β2AR. In mice lacking RPTC β2AR, formoterol treatment failed to rescue serum creatinine, KIM-1 protein expression, and tubular necrosis and only partially restored brush border after IR.

Previous studies have identified RPTCs as central mediators of AKI. After injury, RPTC upregulate inflammatory mediators, such as toll-like receptors, chemokines, and cytokines (Bonventre, 2014). Selective injury of RPTCs using inducible diphtheria toxin can cause AKI in mice and subsequent renal fibrosis, and the degree of RPTC death correlated with AKI severity (Grgic et al., 2012; Takaori et al., 2016). Conversely, increasing RPTC proliferation by treatment with growth factors was associated with enhanced recovery from AKI in rats and dogs (Humes et al., 1989; Miller et al., 1994a,b; Petrinec et al., 1996). In this study, we have shown that mice lacking RPTC β2AR fail to recover renal function after treatment with formoterol. These data underscore the importance of RPTCs and competent RPTC signaling in the pharmacologic treatment of AKI.

The γGT1 promoter has been used by several groups to generate proximal tubule-specific deletions of target genes (Iwano et al., 2002; Chen et al., 2012; Inoue et al., 2012; Tiwari et al., 2013; Han et al., 2016; Zhou et al., 2018). Although γGT1 can also be expressed in hepatocytes, it is expressed in much higher levels in proximal tubule cells (Hanigan et al., 2015), and γGT-Cre mice primarily express Cre in the kidney (Iwano et al., 2002). Further work showed that γGT-Cre deletes floxed genes in only proximal tubule cells (Chen et al., 2012; Inoue et al., 2012; Tiwari et al., 2013; Han et al., 2016). Although γGT isoforms can be expressed by other cell types (Hanigan et al., 2015), particularly in pathologic states such as polycystic kidney disease (Starremans et al., 2008) and epithelial-mesenchymal transition (Inoue et al., 2010), the γGT-Cre mouse generates a proximal tubule-specific deletion of floxed genes without any Cre-dependent effects on renal function.

Despite the numerous pharmacologic modulators for the β2AR, there is a paucity of research on its effects in the kidney, particularly in AKI. In our studies, we found no difference in renal function between WT and KO mice at 24 hours, suggesting that proximal tubule deletion of the β2AR does not impact renal function in terms of the initial injury after IR. Furthermore, we saw no difference in the renal function or histopathology of sham-operated ADRB2Flox/Flox and γGT-Cre:ADRB2Flox/Flox mice. Previous work has shown that although increased β2AR expression enhances glomerular filtration rate (Nakamura et al., 2004), inhibition of the β2AR does not affect renal function but does sensitize animals to septic AKI (Nakamura et al., 2009). Other groups have shown that whole-body deletion of the β1AR and β2AR reduces baseline renin levels but has a normal response to stimulation (Chen et al., 2010; Neubauer et al., 2011). Additionally, deletion of β2AR decreases the activity of a collecting duct-macrophage axis after transverse aortic constriction, although renal function was not measured in these experiments (Fujiu et al., 2017). These effects on renal signaling likely are effects of β2AR inhibition on cell types other than the proximal tubule cell.

Proper balance of MB, fission, and fusion is important for recovery from AKI. Deletion of PGC-1α, a key transcriptional regulator of MB, worsens RPTC injury, whereas its overexpression promotes MB to accelerate recovery (Tran et al., 2011, 2016). Pharmacologic induction of MB accelerates the recovery of mitochondrial and renal function after AKI (Jesinkey et al., 2014; Collier et al., 2016; Collier and Schnellmann, 2017). Formoterol-treated mice lacking the β2AR in RPTC failed to recover mtDNA copy number, mitochondrial protein expression, and mitochondrial number and area after AKI. In addition, sham-operated KO mice had fewer total mitochondria without a decrease in mtDNA copy number and elevated NDUFS1 protein expression. These data provide evidence that the β2AR plays a role in RPTC mitochondrial homeostasis in healthy mice. Whereas previous studies have shown that formoterol increases mRNA, protein, and functional markers of mitochondria in the kidney (Wills et al., 2012; Jesinkey et al., 2014), this study shows for the first time that formoterol induces bona fide MB in RPTC.

In addition to MB, mitochondrial fission and fusion are known to play varying roles in AKI. Because Drp1 and Mfn2 are regulated by the PGC-1α (Soriano et al., 2006; Martin et al., 2014; Dabrowska et al., 2015) and expression of both proteins is restored after formoterol treatment in WT mice, the recovery of Mfn2 and Drp1 is linked to formoterol-induced activation of PGC-1α. Drp1 is thought to be detrimental after injury by enhancing mitochondrial fragmentation, reactive oxygen species production, and apoptosis (Tang et al., 2013). After AKI, mitochondrial fragmentation is increased in RPTC in a Drp1-dependent manner (Brooks et al., 2009), and decreased Mfn2 expression potentiates this fragmentation (Gall et al., 2012; Tsushida et al., 2018). As such, formoterol activation of β2AR and restoration of Drp1 and Mfn2 expression may improve mitochondrial dynamics and contribute to the recovery of mitochondrial function after IRI by affecting mitochondrial dynamics; however, we observed no changes in mitochondrial form factor or individual mitochondrial area among our treatment groups, suggesting that the effects of formoterol on mitochondrial dynamics are secondary to those of formoterol on MB.

In summary, these data underscore the importance of RPTC mitochondria as a therapeutic target, that β2AR regulates renal mitochondrial homeostasis, and that G protein–coupled receptor ligands such as formoterol can induce MB to accelerate recovery from renal function. Since they represent such a large portion of the pharmacopeia, identification of more G protein–coupled receptor ligands that can induce MB in RPTC will provide a greater number of potential therapeutics for AKI.

Acknowledgments

We thank Dr. Zhi Zhong for assistance in initial establishment of the mouse colony.

Author Contributions

Participated in research design: Cameron, Beeson, Schnellmann.

Conducted experiments: Cameron, Gibbs, Miller, Dupre, Megyesi.

Performed data analysis: Cameron, Miller.

Wrote or contributed to the writing of the manuscript: Cameron, Miller, Dupre, Schnellmann.

Footnotes

    • Received August 10, 2018.
    • Accepted January 4, 2019.

  • R.B.C. is funded by [F30 DK104550] and [T32 GM008716] (National Institutes of Health). W.S.G. is funded by [T32 DK083262]. T.V.D. is funded by [T32 HL007249]. C.C.B. is funded by [P20 GM103542] (NIH). R.G.S. is funded by [R01 GM084147] and 1BX000851 (Department of Veterans Affairs).

  • Portions of this work were presented at Experimental Biology 2018.

  • Primary Laboratory: Schnellmann Laboratory, University of Arizona.

  • https://doi.org/10.1124/jpet.118.252833.

  • ↵Embedded ImageThis article has supplemental material available at jpet.aspetjournals.org.

Abbreviations

AKI
acute kidney injury
β2AR
β-2 adrenergic receptor
DMSO
dimethylsulfoxide
Drp1
dynamin-related protein 1
IRI
ischemia-reperfusion injury
KIM-1
kidney injury marker-1
KO
knockout
MB
mitochondrial biogenesis
Mfn2
mitofusin 2
NDUFS1
NADH:ubiquinone oxidoreductase core subunit S1
PCR
polymerase chain reaction
PGC-1α
peroxisome proliferator-activated receptor gamma coactivator-1α
RPTC
renal proximal tubule cell
SCr
serum creatinine
WT
wild-type

References

  1. ↵
    1. Bonventre JV
    (2014) Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis. Kidney Int Suppl (2011) 4:39–44.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Brooks C,
    2. Wei Q,
    3. Cho SG, and
    4. Dong Z
    (2009) Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 119:1275–1285.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Cameron RB,
    2. Beeson CC, and
    3. Schnellmann RG
    (2017) Structural and pharmgpcracological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol. Sci Rep 7:10578.
    OpenUrl
  4. ↵
    1. Chen J,
    2. Chen JK,
    3. Nagai K,
    4. Plieth D,
    5. Tan M,
    6. Lee TC,
    7. Threadgill DW,
    8. Neilson EG, and
    9. Harris RC
    (2012) EGFR signaling promotes TGFβ-dependent renal fibrosis. J Am Soc Nephrol 23:215–224.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Chen L,
    2. Kim SM,
    3. Eisner C,
    4. Oppermann M,
    5. Huang Y,
    6. Mizel D,
    7. Li L,
    8. Chen M,
    9. Sequeira Lopez ML,
    10. Weinstein LS, et al.
    (2010) Stimulation of renin secretion by angiotensin II blockade is Gsalpha-dependent. J Am Soc Nephrol 21:986–992.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Chevalier RL
    (2016) The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am J Physiol Renal Physiol 311:F145–F161.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Collier JB and
    2. Schnellmann RG
    (2017) Extracellular signal-regulated kinase 1/2 regulates mouse kidney injury molecule-1 expression physiologically and following ischemic and septic renal injury. J Pharmacol Exp Ther 363:419–427.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Collier JB,
    2. Whitaker RM,
    3. Eblen ST, and
    4. Schnellmann RG
    (2016) Rapid renal regulation of peroxisome proliferator-activated receptor γ coactivator-1α by extracellular signal-regulated kinase 1/2 in physiological and pathological conditions. J Biol Chem 291:26850–26859.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Dabrowska A,
    2. Venero JL,
    3. Iwasawa R,
    4. Hankir MK,
    5. Rahman S,
    6. Boobis A, and
    7. Hajji N
    (2015) PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity. Aging (Albany NY) 7:629–647.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Fujiu K,
    2. Shibata M,
    3. Nakayama Y,
    4. Ogata F,
    5. Matsumoto S,
    6. Noshita K,
    7. Iwami S,
    8. Nakae S,
    9. Komuro I,
    10. Nagai R, et al.
    (2017) A heart-brain-kidney network controls adaptation to cardiac stress through tissue macrophage activation. Nat Med 23:611–622.
    OpenUrl
  11. ↵
    1. Funk JA and
    2. Schnellmann RG
    (2012) Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am J Physiol Renal Physiol 302:F853–F864.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Gall JM,
    2. Wang Z,
    3. Liesa M,
    4. Molina A,
    5. Havasi A,
    6. Schwartz JH,
    7. Shirihai O,
    8. Borkan SC, and
    9. Bonegio RG
    (2012) Role of mitofusin 2 in the renal stress response. PLoS One 7:e31074.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Grgic I,
    2. Campanholle G,
    3. Bijol V,
    4. Wang C,
    5. Sabbisetti VS,
    6. Ichimura T,
    7. Humphreys BD, and
    8. Bonventre JV
    (2012) Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 82:172–183.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Han X,
    2. Yang J,
    3. Li L,
    4. Huang J,
    5. King G, and
    6. Quarles LD
    (2016) Conditional deletion of Fgfr1 in the proximal and distal tubule identifies distinct roles in phosphate and calcium transport. PLoS One 11:e0147845.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Hanigan MH,
    2. Gillies EM,
    3. Wickham S,
    4. Wakeham N, and
    5. Wirsig-Wiechmann CR
    (2015) Immunolabeling of gamma-glutamyl transferase 5 in normal human tissues reveals that expression and localization differ from gamma-glutamyl transferase 1. Histochem Cell Biol 143:505–515.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Hinoi E,
    2. Gao N,
    3. Jung DY,
    4. Yadav V,
    5. Yoshizawa T,
    6. Myers MG Jr.,
    7. Chua SC Jr.,
    8. Kim JK,
    9. Kaestner KH, and
    10. Karsenty G
    (2008) The sympathetic tone mediates leptin’s inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol 183:1235–1242.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Hoste EA,
    2. Bagshaw SM,
    3. Bellomo R,
    4. Cely CM,
    5. Colman R,
    6. Cruz DN,
    7. Edipidis K,
    8. Forni LG,
    9. Gomersall CD,
    10. Govil D, et al.
    (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411–1423.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Humes HD,
    2. Cieslinski DA,
    3. Coimbra TM,
    4. Messana JM, and
    5. Galvao C
    (1989) Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 84:1757–1761.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Inoue T,
    2. Suzuki H, and
    3. Okada H
    (2012) Targeted expression of a pan-caspase inhibitor in tubular epithelium attenuates interstitial inflammation and fibrogenesis in nephritic but not nephrotic mice. Kidney Int 82:980–989.
    OpenUrlPubMed
  20. ↵
    1. Inoue T,
    2. Takenaka T,
    3. Hayashi M,
    4. Monkawa T,
    5. Yoshino J,
    6. Shimoda K,
    7. Neilson EG,
    8. Suzuki H, and
    9. Okada H
    (2010) Fibroblast expression of an IκB dominant-negative transgene attenuates renal fibrosis. J Am Soc Nephrol 21:2047–2052.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Iwano M,
    2. Plieth D,
    3. Danoff TM,
    4. Xue C,
    5. Okada H, and
    6. Neilson EG
    (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341–350.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Jang HR and
    2. Rabb H
    (2015) Immune cells in experimental acute kidney injury. Nat Rev Nephrol 11:88–101.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Jesinkey SR,
    2. Funk JA,
    3. Stallons LJ,
    4. Wills LP,
    5. Megyesi JK,
    6. Beeson CC, and
    7. Schnellmann RG
    (2014) Formoterol restores mitochondrial and renal function after ischemia-reperfusion injury. J Am Soc Nephrol 25:1157–1162.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Liu BC,
    2. Tang TT,
    3. Lv LL, and
    4. Lan HY
    (2018) Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int 93:568–579.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Martin OJ,
    2. Lai L,
    3. Soundarapandian MM,
    4. Leone TC,
    5. Zorzano A,
    6. Keller MP,
    7. Attie AD,
    8. Muoio DM, and
    9. Kelly DP
    (2014) A role for peroxisome proliferator-activated receptor γ coactivator-1 in the control of mitochondrial dynamics during postnatal cardiac growth. Circ Res 114:626–636.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Miller SB,
    2. Martin DR,
    3. Kissane J, and
    4. Hammerman MR
    (1994a) Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 266:F129–F134.
    OpenUrl
  27. ↵
    1. Miller SB,
    2. Martin DR,
    3. Kissane J, and
    4. Hammerman MR
    (1994b) Rat models for clinical use of insulin-like growth factor I in acute renal failure. Am J Physiol 266:F949–F956.
    OpenUrl
  28. ↵
    1. Molitoris BA
    (2014) Therapeutic translation in acute kidney injury: the epithelial/endothelial axis. J Clin Invest 124:2355–2363.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Moore PK,
    2. Hsu RK, and
    3. Liu KD
    (2018) Management of acute kidney injury: core curriculum 2018. Am J Kidney Dis 72:136–148.
    OpenUrl
  30. ↵
    1. Nakamura A,
    2. Imaizumi A,
    3. Niimi R,
    4. Yanagawa Y,
    5. Kohsaka T, and
    6. Johns EJ
    (2005) Adenoviral delivery of the beta2-adrenoceptor gene in sepsis: a subcutaneous approach in rat for kidney protection. Clin Sci (Lond) 109:503–511.
    OpenUrlPubMed
  31. ↵
    1. Nakamura A,
    2. Imaizumi A,
    3. Yanagawa Y,
    4. Kohsaka T, and
    5. Johns EJ
    (2004) beta(2)-Adrenoceptor activation attenuates endotoxin-induced acute renal failure. J Am Soc Nephrol 15:316–325.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    1. Nakamura A,
    2. Imaizumi A,
    3. Yanagawa Y,
    4. Niimi R,
    5. Kohsaka T, and
    6. Johns EJ
    (2003) Beta2-adrenoceptor activation inhibits Shiga toxin2-induced apoptosis of renal tubular epithelial cells. Biochem Pharmacol 66:343–353.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Nakamura A,
    2. Niimi R,
    3. Imaizumi A, and
    4. Yanagawa Y
    (2007) Renal effects of beta2-adrenoceptor agonist and the clinical analysis in children. Pediatr Res 61:129–133.
    OpenUrlPubMed
  34. ↵
    1. Nakamura A,
    2. Niimi R, and
    3. Yanagawa Y
    (2009) Renal beta(2)-adrenoceptor modulates the lipopolysaccharide transport system in sepsis-induced acute renal failure. Inflammation 32:12–19.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Nakamura A,
    2. Niimi R, and
    3. Yanagawa Y
    (2010) Protection from sepsis-induced acute renal failure by adenoviral-mediated gene transfer of beta2-adrenoceptor. Nephrol Dial Transplant 25:730–737.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Nakamura M,
    2. Shirai A,
    3. Yamazaki O,
    4. Satoh N,
    5. Suzuki M,
    6. Horita S,
    7. Yamada H, and
    8. Seki G
    (2014) Roles of renal proximal tubule transport in acid/base balance and blood pressure regulation. BioMed Res Int 2014:504808.
    OpenUrl
  37. ↵
    1. Neubauer B,
    2. Machura K,
    3. Schnermann J, and
    4. Wagner C
    (2011) Renin expression in large renal vessels during fetal development depends on functional beta1/beta2-adrenergic receptors. Am J Physiol Renal Physiol 301:F71–F77.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Petrinec D,
    2. Reilly JM,
    3. Sicard GA,
    4. Lowell JA,
    5. Howard TK,
    6. Martin DR,
    7. Brennan DC, and
    8. Miller SB
    (1996) Insulin-like growth factor-I attenuates delayed graft function in a canine renal autotransplantation model. Surgery 120:221–225; discussion 225–226.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Puigserver P,
    2. Wu Z,
    3. Park CW,
    4. Graves R,
    5. Wright M, and
    6. Spiegelman BM
    (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829–839.
    OpenUrlCrossRefPubMed
  40. ↵
    1. Ralto KM and
    2. Parikh SM
    (2016) Mitochondria in acute kidney injury. Semin Nephrol 36:8–16.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Sekine M,
    2. Monkawa T,
    3. Morizane R,
    4. Matsuoka K,
    5. Taya C,
    6. Akita Y,
    7. Joh K,
    8. Itoh H,
    9. Hayashi M,
    10. Kikkawa Y, et al.
    (2012) Selective depletion of mouse kidney proximal straight tubule cells causes acute kidney injury. Transgenic Res 21:51–62.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Soriano FX,
    2. Liesa M,
    3. Bach D,
    4. Chan DC,
    5. Palacín M, and
    6. Zorzano A
    (2006) Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. Diabetes 55:1783–1791.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Starremans PG,
    2. Li X,
    3. Finnerty PE,
    4. Guo L,
    5. Takakura A,
    6. Neilson EG, and
    7. Zhou J
    (2008) A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5′ end of Pkd1. Kidney Int 73:1394–1405.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Susantitaphong P,
    2. Cruz DN,
    3. Cerda J,
    4. Abulfaraj M,
    5. Alqahtani F,
    6. Koulouridis I,
    7. Jaber BL, and Acute Kidney Injury Advisory Group of the American Society of Nephrology
    (2013) World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol 8:1482–1493.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Takaori K,
    2. Nakamura J,
    3. Yamamoto S,
    4. Nakata H,
    5. Sato Y,
    6. Takase M,
    7. Nameta M,
    8. Yamamoto T,
    9. Economides AN,
    10. Kohno K, et al.
    (2016) Severity and frequency of proximal tubule injury determines renal prognosis. J Am Soc Nephrol 27:2393–2406.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Tang WX,
    2. Wu WH,
    3. Qiu HY,
    4. Bo H, and
    5. Huang SM
    (2013) Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of Drp-1 translocation. J Nephrol 26:1073–1082.
    OpenUrlCrossRefPubMed
  47. ↵
    1. Tiwari S,
    2. Singh RS,
    3. Li L,
    4. Tsukerman S,
    5. Godbole M,
    6. Pandey G, and
    7. Ecelbarger CM
    (2013) Deletion of the insulin receptor in the proximal tubule promotes hyperglycemia. J Am Soc Nephrol 24:1209–1214.
    OpenUrlAbstract/FREE Full Text
  48. ↵
    1. Tran M,
    2. Tam D,
    3. Bardia A,
    4. Bhasin M,
    5. Rowe GC,
    6. Kher A,
    7. Zsengeller ZK,
    8. Akhavan-Sharif MR,
    9. Khankin EV,
    10. Saintgeniez M, et al.
    (2011) PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice. J Clin Invest 121:4003–4014.
    OpenUrlCrossRefPubMed
  49. ↵
    1. Tran MT,
    2. Zsengeller ZK,
    3. Berg AH,
    4. Khankin EV,
    5. Bhasin MK,
    6. Kim W,
    7. Clish CB,
    8. Stillman IE,
    9. Karumanchi SA,
    10. Rhee EP, et al.
    (2016) PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection. Nature 531:528–532.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Tsushida K,
    2. Tanabe K,
    3. Masuda K,
    4. Tanimura S,
    5. Miyake H,
    6. Arata Y,
    7. Sugiyama H, and
    8. Wada J
    (2018) Estrogen-related receptor α is essential for maintaining mitochondrial integrity in cisplatin-induced acute kidney injury. Biochem Biophys Res Commun 498:918–924.
    OpenUrl
  51. ↵
    1. Wills LP,
    2. Trager RE,
    3. Beeson GC,
    4. Lindsey CC,
    5. Peterson YK,
    6. Beeson CC, and
    7. Schnellmann RG
    (2012) The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis. J Pharmacol Exp Ther 342:106–118.
    OpenUrlAbstract/FREE Full Text
  52. ↵
    1. Zhou T,
    2. Luo M,
    3. Cai W,
    4. Zhou S,
    5. Feng D,
    6. Xu C, and
    7. Wang H
    (2018) Runt-related transcription factor 1 (RUNX1) promotes TGF-β-induced renal tubular epithelial-to-mesenchymal transition (EMT) and renal fibrosis through the PI3K subunit p110δ. EBioMedicine 31:217–225.
    OpenUrl
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleCardiovascular

RPTC β-Adrenergic Receptor and AKI

Robert B. Cameron, Whitney S. Gibbs, Siennah R. Miller, Tess V. Dupre, Judit Megyesi, Craig C. Beeson and Rick G. Schnellmann
Journal of Pharmacology and Experimental Therapeutics April 1, 2019, 369 (1) 173-180; DOI: https://doi.org/10.1124/jpet.118.252833
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement